medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2011, Number 2

<< Back Next >>

Rev Esp Med Quir 2011; 16 (2)

Metabolic and renal profile of population attending to medical consultation in a second level of care

Méndez DA, Rivera ALL, Bonfil RMI, Navarrete HF, Lizcano EF, Guerrero AJ

Language: Spanish
References: 26
Page: 104-109
PDF size: 372.91 Kb.


ABSTRACT

Background: Most of the adult population has cardiovascular and renal risk factors associated with the onset, worsening or uncontrolled chronic diseases; those related to chronic kidney disease (CKD) may be present at birth or acquired at different life stages and combined to accelerate the progression of CKD.
Objective: To identify the metabolic and renal profile of an adult population that attends a medical consultation of a second level of care.
Material and methods: A retrospective study and analysis, conducted in CE Leonardo Bravo, ISSSTE, from February 1 to June 30, 2010. We identified demographic characteristics, family history of CKD and associated cardiovascular and renal risk factors.
Results: We included 71 adults (37 males and 34 females), 30 diabetics (41%) and 41 hypertensive (59%) of 60.1 years old (range: 30 to 99); 20 (28%) had history of smoking and 11 (15%) of intake of alcohol. Body mass index of 30.3 (range: 20.7 to 45.6), fasting plasma glucose was 128.2 mg/dL (range: 75 to 336), serum creatinine 1.2 mg/dL (0.7, range: 0.4 to 7), total cholesterol 207.5 mg/dL (range: 104 to 450), triglycerides 222.7 mg/dL (range :49 to 995), uric acid 5.9 mg/dL (range: 2.4 to 9.9) and the DCR of 91.8 mL/min (range: 8.4 to 178); five cardiovascular and renal risk factors were found on average.
Conclusions: cardiovascular and renal risk factors occurred equally in diabetic and hypertensive; one in three patients had deterioration of renal function. Overweight and obesity were the most frequent conditions and were associated with a decreased glomerular filtration rate.


REFERENCES

  1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.

  2. Martínez I. Enfermedad renal crónica: indicaciones para remitir pacientes desde el nivel de atención primaria al nivel de especialista en nefrología. Ventajas del envío precoz. Estrategias para el seguimiento conjunto. Nefrología 2004;24(suppl 6):84-90.

  3. Méndez-Durán A, Méndez-Bueno JF, Tapia-Yáñez T, Muñoz-Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal crónica en México. Dial Transplant 2010;31(1):7-11.

  4. Diagnosis and classification of diabetes mellitus. American Diabetes Association. Diabetes Care 2009;32(suppl 1).

  5. Cole T, Bellizzi M, Flegal K, Dietz W. Establishing a standard definition of child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.

  6. Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart Lung and Blood Institute. Circulation 2004;110:227-239.

  7. KDOQI Guidelines. 2000 National Kidney Foundation. Am J Kidn Dis 2002;39:2(suppl 1).

  8. Zoccali C, Kramer A, Jager Kit J. Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant 2010;25:1731-1733.

  9. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, et al. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. Am Soc Nephrol 2003;14:2934-2941.

  10. II Conteo de población y vivienda 2005. Población total por entidad federativa, sexo y grupos quinquenales de edad según condición de derechohabiencia a servicios de salud y tipo de institución. México: Instituto Nacional de Geografía y Estadística (INEGI), 2005.

  11. Anuarios ISSSTE 2009. www.issste.gob.mx/issste/anuarios/

  12. Takamalsu N, Abe H, Tominaga T, Nakahara K, et al. Risk factors for chronic kidney disease in Japan a communitybased study. BMC Nephrology 2009;10:34.

  13. Ruiz-Fernández N, Espinoza M, Barrios E, Reigosa A. Factores cardiometabólicos en una comunidad de Valencia, Venezuela. Rev Salud Pública 2009;11(3):383-394.

  14. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003;108;2154-2169.

  15. Otero-Raviña F, Grigorian-Shamagian L, Lado-López M, Lado Llerena A, et al. Asociación entre hipertensión refractaria y riesgo cardiometabólico. Estudio HIPERFRE. Nefrología 2008;28(4):425-432.

  16. Lastra G, Manrique C, McFarlane SI, Sowers JR. Cardiometabolic syndrome and chronic kidney disease. Curr Diab Rep 2006;6:207-212.

  17. Ejerblad E, Fored C, Michael, Lidblad P, et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004; 15:2178-2185.

  18. Gómez P, Ruilope LM, Barrios V, Navarro J, et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH Study. J Am Soc Nephrol 2006;17:S194-S200.

  19. Perichart-Perera O, Balas-Nakash M, Ortiz-Rodríguez V, Morán-Zenteno JA. Programa para mejorar marcadores de riesgo cardiovascular en escolares mexicanos. Salud Publica Mex 2008;50(3):218-226.

  20. Paragano A, Machado R, Abdala A, Cordero D. Prevalencia de la hipertensión arterial según los distintos componentes del síndrome metabólico y su vínculo con ellos. Rev Argent Cardiol 2009;77(4):274-279.

  21. Fort J. Chronic renal failure: A cardiovascular risk factor. Kidney Int 2005;68(suppl 99):S25-S29.

  22. Herrera-Bello AC, Hernández-Pérez OA, Méndez-Gálvez LM, Camozo-Chaviano C. Detección de la enfermedad renal crónica en la diabetes mellitus en un área de salud. Dial Transplant 2007;28(3):98-109.

  23. American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003;26(suppl 1):S94.

  24. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G. Grupo ENSA 2000. Hipertensión arterial en México: resultados de la encuesta nacional de salud (ENSA) 2000. Arch Cardiol Méx 2002;72(1):71-84.

  25. Martín de Francisco AL, Aguilera L, Fuster V. Enfermedad cardiovascular, enfermedad renal y otras enfermedades crónicas. Es necesaria una intervención más temprana en la enfermedad renal crónica. Nefrología 2009;29(1):6-9.

  26. Buitrago F. Prevalencia de insuficiencia renal oculta estimada mediante fórmulas de cálculo del grado de función renal en hipertensos mayores de 60 años remitidos para medición ambulatoria de la presión arterial. Aten Primaria 2007;39(5):247-253.




2020     |     www.medigraphic.com